MYMD PHARMACEUTICALS INC (MYMD) Stock Analyst Earnings Estimates
NASDAQ:MYMD - Nasdaq - US62856X2018 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.96M 39.62% | 3.35M 13.18% | 1.67M -50.15% | N/A -100.00% | N/A | N/A | N/A | |
| EBITDA YoY % growth | -3.04M 65.88% | -6.36M -109.21% | -8.32M -30.82% | N/A 60.10% | N/A -269.28% | N/A -134.91% | N/A | |
| EBIT YoY % growth | -3.33M 63.84% | -6.61M -98.50% | -8.55M -29.35% | N/A 60.35% | N/A -262.54% | N/A -134.34% | N/A 46.94% | |
| Operating Margin | -112.50% | -197.31% | -511.98% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A 100.00% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2020 Q2Q % growth | 100.00% | % | ||
| Q1 2020 Q2Q % growth | -100.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |